A diagnosis of cancer may feel devastating. Pancreatic cancer is the least survivable cancer of all known cancers. That’s because when it is diagnosed, it often has already spread.
Dr. Mark Truty, a surgical oncologist at Mayo Clinic, says the stigma around the diagnosis can leave people feeling hopeless. He wants people with pancreatic cancer to know that advances in treatment mean more options are available than ever before.
Watch: Advances in treating pancreatic cancer mean options and hope
“If you think about it — breast cancer, prostate cancer, lung cancer, brain cancer — pancreas cancer continues to be the least survivable of all of those cancers,” says Dr. Truty.
But it is more survivable now than it used to be. Dr. Truty says that’s due in part to advances in the approach to treating the cancer.
Patients that can have surgery for their pancreatic cancer live longer than those who cannot. Unfortunately, in the past, surgery wasn’t an option for most patients, but with better chemotherapy came dramatic changes. Now, more patients are considered candidates for curative surgery.
“Those patients that are able to undergo chemotherapy prior to the surgery tend to do much better than they historically have done,” Dr. Truty says.
That includes patients who may have been considered inoperable elsewhere due to complex tumors involving blood vessels. Mayo Clinic is the first and only center that routinely uses positron emission tomography, or PET, scans to help determine if that chemotherapy is effective.
“This is what we want to see at the beginning; we want to see a tumor lighting up really bright prior to chemotherapy. And then, after chemotherapy, we want to see it sort of disappear — the activity that would suggest that chemotherapy was effective. And then when we ultimately operate on these patients and we take the tumors out, the pathologist tells us that all the cancer is dead,” explains Dr. Truty.
The primary goal for any patient with pancreatic cancer is to extend their life and maintain or improve their quality of life. Advances like this are offering patients hope.
“Oh, without question, they should have hope,” Dr. Truty says.
Read more:
- AI applied to prediagnostic CTs may help diagnose pancreatic cancer at earlier, more treatable stage.
- Identifying inherited gene mutations in pancreatic cancer can lead to targeted therapies, better survival.
- Consumer Health: Pancreatic cancer risks and prevention.
The post Advances in treating pancreatic cancer mean options and hope–2022 appeared first on Mayo Clinic News Network.
“Courtesy: Mayo Clinic News Network.”
Republished with permission[/vc_message]
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components
This article originally appeared here and was republished with permission.
